Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 372,260 | 338,341 | 297,304 | 264,192 | 242,077 |
| Marketable Securities | 2,305,176 | 1,901,830 | 1,992,676 | 1,880,960 | 2,055,579 |
| Receivables | 66,059 | 24,608 | 52,580 | 39,707 | 92,188 |
| Inventories | 10,048 | 10,470 | 8,481 | 11,502 | 12,512 |
| Other current assets | 237,092 | 243,744 | 226,109 | 222,571 | 217,934 |
| TOTAL | $2,990,635 | $2,518,993 | $2,577,150 | $2,418,932 | $2,620,290 |
| Non-Current Assets | |||||
| PPE Net | 123,048 | 106,117 | 111,951 | 102,925 | 94,251 |
| Other Non-Current Assets | 410,153 | 407,981 | 296,032 | 291,091 | 289,134 |
| TOTAL | $533,201 | $514,098 | $407,983 | $394,016 | $383,385 |
| Total Assets | $3,523,836 | $3,033,091 | $2,985,133 | $2,812,948 | $3,003,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 431,948 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 28,082 | 14,326 | 22,800 | 17,456 | 42,964 |
| Accrued Expenses | 222,325 | 156,329 | 145,521 | 129,310 | 178,052 |
| Other current liabilities | 22,738 | 24,803 | 22,806 | 22,304 | 9,279 |
| TOTAL | $781,567 | $903,456 | $897,236 | $250,293 | $309,318 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,118 | N/A | 59,074 | N/A | 51,924 |
| Deferred Revenues | 73,761 | 76,986 | 75,910 | 81,097 | 78,989 |
| Other Non-Current Liabilities | 2,133,061 | 1,403,762 | 1,272,004 | 1,946,251 | 1,897,578 |
| TOTAL | $2,253,180 | $1,511,668 | $1,456,173 | $2,086,929 | $2,106,006 |
| Total Liabilities | $3,034,747 | $2,415,124 | $2,353,409 | $2,337,222 | $2,415,324 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,192 | 161,974 | 159,391 | 159,159 | 158,965 |
| Common Shares | 163 | 161 | 159 | 159 | 158 |
| Retained earnings | -2,631,195 | -2,401,801 | -2,273,195 | -2,396,746 | -2,249,808 |
| Other shareholders' equity | -25,281 | -25,978 | -27,987 | -28,949 | -30,811 |
| TOTAL | $489,089 | $617,967 | $631,724 | $475,726 | $588,351 |
| Total Liabilities And Equity | $3,523,836 | $3,033,091 | $2,985,133 | $2,812,948 | $3,003,675 |